Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A E Rosling

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
The American Journal of Medicine|July 20, 1982
Renal function after acyclovir intravenous injectionD Brigden, A E Rosling, N C Woods
The British Journal of Dermatology|August 1, 1978
The release of beta glucuronidase from the white cells of patients with drug rashes when incubated in autologous plasma, with and without the addition of the causal drugB Watson, E L Rhodes, A E Rosling
Clinical and Experimental Dermatology|June 1, 1977
Leukocyte migration inhibition studies in sarcoidosis with evidence of a serum blocking factorA E Rosling, B Watson, E L Rhodes
Clinical and Experimental Dermatology|March 1, 1978
Removal of a blocking factor from the sera of patients with systematic lupus erythematosus with LevamisoleA E Rosling, E L Rhodes, B Watson
Antiviral Research|November 1, 1981
Acyclovir - a review of the preclinical and early clinical data of a new antiherpes drugD Brigden, P Fiddian, A E Rosling, et al.
Clinical and Experimental Dermatology|December 1, 1978
Neutrophil function in some skin diseases using zymosan as a stimulus in the nitro-blue tetrazolium testA E Rosling, E L Rhodes, B Watson, et al.
The British Journal of Dermatology|April 1, 1977
The release of beta glucuronidase from leukocytes in the presence of immune complexesB Watson, R W Gange, E L Rhodes, et al.
British Medical Journal (Clinical Research Ed.)|August 6, 1983
Acyclovir prophylaxis against herpes virus infections in severely immunocompromised patients: randomised double blind trialI M Hann, H G Prentice, H A Blacklock, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
The American Journal of Medicine|July 20, 1982
Renal function after acyclovir intravenous injectionD Brigden, A E Rosling, N C Woods
The British Journal of Dermatology|August 1, 1978
The release of beta glucuronidase from the white cells of patients with drug rashes when incubated in autologous plasma, with and without the addition of the causal drugB Watson, E L Rhodes, A E Rosling
Clinical and Experimental Dermatology|June 1, 1977
Leukocyte migration inhibition studies in sarcoidosis with evidence of a serum blocking factorA E Rosling, B Watson, E L Rhodes
Clinical and Experimental Dermatology|March 1, 1978
Removal of a blocking factor from the sera of patients with systematic lupus erythematosus with LevamisoleA E Rosling, E L Rhodes, B Watson
Antiviral Research|November 1, 1981
Acyclovir - a review of the preclinical and early clinical data of a new antiherpes drugD Brigden, P Fiddian, A E Rosling, et al.
Clinical and Experimental Dermatology|December 1, 1978
Neutrophil function in some skin diseases using zymosan as a stimulus in the nitro-blue tetrazolium testA E Rosling, E L Rhodes, B Watson, et al.
The British Journal of Dermatology|April 1, 1977
The release of beta glucuronidase from leukocytes in the presence of immune complexesB Watson, R W Gange, E L Rhodes, et al.
British Medical Journal (Clinical Research Ed.)|August 6, 1983
Acyclovir prophylaxis against herpes virus infections in severely immunocompromised patients: randomised double blind trialI M Hann, H G Prentice, H A Blacklock, et al.
Pageof 1